The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer
1 other identifier
observational
110
1 country
1
Brief Summary
Investigators conducted an observational diagnostic study. The primary objective of the study is to develop a scoring system for detecting pre-lung cancer abnormalities using narrow-band imaging (NBI) bronchoscopy. From the collected data, investigators will perform a multivariate analysis based on the odds ratio (OR) using IBM SPSS software. The result of the data analysis will be transformed into a scoring system aimed to facilitate the early diagnosis of lung cancer, specifically at the pre-cancer stage. This scoring system will also help clinicians detect pre-cancerous abnormalities early and improve patient recovery prospects. Several research questions to be addressed are as follows:
- 1.What are the NBI image criteria for detecting pre-cancerous lesions in lung tumor patients?
- 2.What is the diagnostic profile of NBI bronchoscopy in detecting pre-cancerous lesions in lung tumor patients?
- 3.Can adding the NBI bronchoscopy procedure to the standard bronchoscopy procedure enhance the diagnostic accuracy in detecting pre-cancerous lesions in lung tumor patients?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2023
CompletedFirst Submitted
Initial submission to the registry
October 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedMarch 6, 2024
March 1, 2024
1 year
October 22, 2023
March 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the sensitivity, specificity, positive predictive value, and negative predictive value of the bronchoscopic narrow-band imaging (NBI) in detecting bronchial squamous dysplasia
To address this outome, researchers will utilize parameters derived form NBI bronchoscopy images, consist of normal vascularity, increased vascular frequency, dotted, spiral, tortuous and abrupt-ending blood vessels (on a nominal scale). These parameters will be employed in conjunction with histopathological images (dysplasia or non dysplasia) for comparative analysis
Based on the research timeline, all statistical analysis and data processing will be conducted from January to February 2024
Secondary Outcomes (2)
To determine the proportion of bronchial squamous dysplasia in lung cancer patients
Based on the research timeline, all statistical analysis and data processing will be conducted from January to February 2024
To establish the correlation between the NBI bronchoscopy findings and bronchial squamous dysplasia in lung cancer patients
Based on the research timeline, all statistical analysis and data processing will be conducted from January to February 2024
Eligibility Criteria
1. Population: The target population consists of all lung tumor patients. The accessible population consisted of lung tumor patients who underwent bronchoscopy procedures at Persahabatan Hospital from March to December 2023. 2. The study participants: The study participants comprised individuals from the accessible population who met the research subject acceptance criteria and provided informed consent. The consecutive sampling method was employed. 3. The study participants size calculation: The study participants size was calculated using the diagnostic research sample size formula. The minimum study participants size required was 110 subjects.
You may qualify if:
- Patients aged \>18 years undergoing bronchoscopy for diagnostic evaluation of lung tumors.
- Recent radiological examinations, including both chest X-rays and chest CT scans, within the last month, revealed central lesions.
You may not qualify if:
- Refusal to provide informed consent
- Contraindications to bronchoscopy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Biospecimen
formalin-fixed paraffin-embedded (FFPE) tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 22, 2023
First Posted
October 26, 2023
Study Start
March 27, 2023
Primary Completion
March 31, 2024
Study Completion
October 30, 2024
Last Updated
March 6, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Researchers might be engaging in consultations with ethics boards, legal experts, and stakeholders to develop a robust and ethical sharing plan that adheres to the highest standards of privacy and security.